Cardiol.br - Home - Cardiol Therapeutics

Provided by Alexa ranking, cardiol.br has ranked N/A in N/A and 8,490,530 on the world. cardiol.br reaches roughly 363 users per day and delivers about 10,879 users each month. The domain cardiol.br uses a Commercial suffix and it's server(s) are located in N/A with the IP number 200.209.23.52 and it is a .br domain.

WEBHeal the heart with innovative science. We are a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. Corporate Presentation View Pipeline.

List of domain same IP 200.209.23.52

Keywords on this domain

Search Results related to cardiol.br on Search Engine

Home - Cardiol Therapeutics
cardiolrx.com

https://www.cardiolrx.com/

WEBHeal the heart with innovative science. We are a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. Corporate Presentation View Pipeline.

DA: 35 PA: 15 MOZ Rank: 29

Cardiol Therapeutics Announces Study Results Demonstrating …
cardiolrx.com

https://www.cardiolrx.com/cardiol-therapeutics-announces-study-results-demonstrating-protective-effects-of-cardiolrx-in-a-model-of-acute-pericarditis/

WEBOakville, ON – November 7, 2022 – Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (“Cardiol” or the “Company”), a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases, announced today study results demonstrating ...

DA: 52 PA: 14 MOZ Rank: 11

Cardiol Therapeutics Announces First Patient Enrolled in Phase II …
cardiolrx.com

https://www.cardiolrx.com/cardiol-therapeutics-announces-first-patient-enrolled-in-phase-ii-study-evaluating-cardiolrx-for-the-treatment-of-recurrent-pericarditis/

WEBJan 17, 2023 · Cardiol Therapeutics Announces First Patient Enrolled in Phase II Study Evaluating CardiolRx™ for the Treatment of Recurrent Pericarditis. The Cleveland Clinic Recruits First Participant in the Multi-center U.S. Study. Oakville, ON – January 17, 2023 – Cardiol Therapeutics Inc. ( NASDAQ: CRDL) ( TSX: CRDL) ( “Cardiol” or the ...

DA: 14 PA: 99 MOZ Rank: 100

Cardiol Therapeutics Inc. (CRDL) - Yahoo Finance
yahoo.com

https://finance.yahoo.com/quote/CRDL

WEB1.0700. -1.83%. Find the latest Cardiol Therapeutics Inc. (CRDL) stock quote, history, news and other vital information to help you with your stock trading and investing.

DA: 55 PA: 67 MOZ Rank: 26

CRDL Stock Price | Cardiol Therapeutics Inc. Stock Quote (U.S.: …
marketwatch.com

https://www.marketwatch.com/investing/stock/crdl

WEB4 days ago · CRDL | Complete Cardiol Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

DA: 99 PA: 19 MOZ Rank: 80

Cardiol Therapeutics Inc. (CRDL) - Yahoo Finance
yahoo.com

https://finance.yahoo.com/quote/CRDL/news/

WEBGet the latest Cardiol Therapeutics Inc. (CRDL) stock news and headlines to help you in your trading and investing decisions.

DA: 86 PA: 9 MOZ Rank: 82

CRDL | Cardiol Therapeutics Inc. Stock Price & News - WSJ
wsj.com

https://www.wsj.com/market-data/quotes/CRDL

WEBView the latest Cardiol Therapeutics Inc. (CRDL) stock price, news, historical charts, analyst ratings and financial information from WSJ.

DA: 75 PA: 48 MOZ Rank: 41

Cardiol Therapeutics Inc. Class A Common Shares - Nasdaq
nasdaq.com

https://www.nasdaq.com/market-activity/stocks/crdl

WEBDiscover real-time Cardiol Therapeutics Inc. Class A Common Shares (CRDL) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions.

DA: 51 PA: 92 MOZ Rank: 53

CRDL - Cardiol Therapeutics Inc Stock Price and Quote
finviz.com

https://finviz.com/quote.ashx?t=CRDL

WEBCardiol Therapeutics, Inc. is a clinical-stage life sciences company focused on the research and clinical of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease.

DA: 13 PA: 18 MOZ Rank: 40

Carvedilol - StatPearls - NCBI Bookshelf
nih.gov

https://www.ncbi.nlm.nih.gov/books/NBK534868/

WEBJan 10, 2024 · Carvedilol, a nonselective adrenergic blocker, is indicated for HFrEF, hypertension, and left ventricular dysfunction following myocardial infarction in clinically stable patients. Effective management of these conditions with this agent necessitates the coordinated involvement of an interprofessional healthcare team.

DA: 96 PA: 59 MOZ Rank: 69

Alexa Rank

GLOBAL RANK

8,490,530

Alexa Reach

0.0000160080

Page length

N/A

Alexa Rank Country N/A

N/A

Daily Unique Visitors

363

Monthly Unique Visitors

10,879

Vistor via Country

Country lang

Country code

Total visitor

Country

Country code

Total visitor

United States

2,327

Indonesia

1,820

Taiwan

592

United Kingdom

525

Brazil

475

Nigeria

416

Egypt

349

Hong Kong

330

Canada

330

Australia

287

Philippines

206

India

200

Malaysia

197

Spain

163

Germany

159

Mexico

152

France

144

Italy

133

Turkey

122

Iraq

111

Thailand

109

Netherlands

104

Israel

103

Cambodia

Algeria

Ireland

Romania

Jordan

Poland

Ghana

Argentina

South Africa

Belgium

Czechia

Ukraine

Japan

Morocco

South Korea

Lebanon

Saudi Arabia

Austria

Hungary

Sweden

Singapore

Pakistan

Bangladesh

Denmark

Greece

Alexa Traffic Graph

Alexa daily traffic trend graph

Alexa daily pageviews (percent) graph

Alexa Statistics Graph for www.nahklick.de

Alexa daily pageviews per user graph

Alexa time on site (in minutes) graph

Alexa bounce rate (percent) graph

Alexa search visits graph

SEOquake Zone

Title			Tips
Description			Tips
Keywords			Tips
Viewport			Tips
Icon
UTF-8

Mini site formation by Alexa Rank

MOZ Rank

DNS Record

Host	Type	Class	TTL	Extra
cardiol.br	TXT	IN	3600	Txt: MS=ms35178315 Entries_0: MS=ms35178315
cardiol.br	TXT	IN	3600	Txt: v=spf1 include:_spf.google.com ~all Entries_0: v=spf1 include:_spf.google.com ~all
cardiol.br	MX	IN	300	Pri: 10 Target: alt3.aspmx.l.google.com
cardiol.br	MX	IN	300	Pri: 1 Target: aspmx.l.google.com
cardiol.br	MX	IN	300	Pri: 5 Target: alt2.aspmx.l.google.com
cardiol.br	MX	IN	300	Pri: 5 Target: alt1.aspmx.l.google.com
cardiol.br	MX	IN	300	Pri: 10 Target: alt4.aspmx.l.google.com
cardiol.br	SOA	IN	21600	Mname: ns-cloud-e1.googledomains.com Rname: cloud-dns-hostmaster.google.com Serial: 1 Refresh: 21600 Retry: 3600 Expire: 1209600 Minimum-ttl: 300
cardiol.br	NS	IN	21600	Target: ns-cloud-e3.googledomains.com
cardiol.br	NS	IN	21600	Target: ns-cloud-e1.googledomains.com
cardiol.br	NS	IN	21600	Target: ns-cloud-e4.googledomains.com
cardiol.br	NS	IN	21600	Target: ns-cloud-e2.googledomains.com
cardiol.br	A	IN	300	Ip: 200.209.23.52

Hosting and Whois Zone

IP	200.209.23.52
Domain infomation	% Copyright (c) Nic.br % The use of the data below is only permitted as described in % full by the Use and Privacy Policy at https://registro.br/upp , % being prohibited its distribution, commercialization or % reproduction, in particular, to use it for advertising or % any similar purpose. % 2024-04-23T19:27:36-03:00 - IP: 2604:a880:4:1d0::5bb:800f domain: cardiol.br owner: SOCIEDADE BRASILEIRA DE CARDIOLOGIA ownerid: 31.444.094/0001-11 responsible: Rafael Botelho de Paiva country: BR owner-c: ORC2 tech-c: ORC2 nserver: ns-cloud-e1.googledomains.com nsstat: 20240423 AA nslastaa: 20240423 nserver: ns-cloud-e2.googledomains.com nsstat: 20240423 AA nslastaa: 20240423 nserver: ns-cloud-e3.googledomains.com nsstat: 20240423 AA nslastaa: 20240423 nserver: ns-cloud-e4.googledomains.com nsstat: 20240423 AA nslastaa: 20240423 created: 19960514 #7739 changed: 20200518 status: published nic-hdl-br: ORC2 person: Orlando Castro e-mail: [email protected] country: BR created: 19971224 changed: 20210211 % Security and mail abuse issues should also be addressed to % cert.br, http://www.cert.br/ , respectivelly to [email protected] % and [email protected] % % whois.registro.br accepts only direct match queries. Types % of queries are: domain (.br), registrant (tax ID), ticket, % provider, CIDR block, IP and ASN.